Qu et al. discovered the involvement of KLF15 in glioma tumor drug resistance, and their functional tests revealed that knocking down KLF15 increased glioma sensitivity to temozolomide cytotoxicity via modulating O6-methylguanine-DNA methyltransferase expression. This evidence concerns the gene KLF15 and central nervous system cancer.